Development of a Medication-Use Evaluation Template for Andexanet Alfa in the Reversal of Anticoagulation With Factor Xa Inhibitors.

Saved in:
Bibliographic Details
Title: Development of a Medication-Use Evaluation Template for Andexanet Alfa in the Reversal of Anticoagulation With Factor Xa Inhibitors.
Authors: Fera T; Project Consultant, Greater Pittsburgh Area, PA, USA., Burnett A; Inpatient Antithrombosis Stewardship Service, University of New Mexico Hospital, Albuquerque, NM, USA., Grandoni J; Department of Pharmacy, Brigham and Women's Hospital, Boston, MA, USA., Moore MR; Mass General Brigham, Boston, MA, USA., Nussbaum BB; ASHP Research and Education Foundation, Bethesda, MD, USA., Pollack CV Jr; Department of Emergency Medicine, University of Mississippi, Jackson, MS, USA., Rose AE; Department of Pharmacy, UW Health, Madison, WI, USA., Spinler SA; Department of Pharmacy Practice, Binghamton University School of Pharmacy and Pharmaceutical Sciences, Binghamton, NY, USA., Streiff MB; Department of Medicine, Division of Hematology, The Johns Hopkins University, Baltimore, MD, USA., Turck CJ; Scientia Perpetuam, LLC, Greater Chicago Area, IL, USA.; ScientiaCME, Inc., Los Angeles, CA, USA., Fanikos J; North American Thrombosis Forum, Brookline, MA, USA.
Source: Journal of pharmacy practice [J Pharm Pract] 2025 Feb; Vol. 38 (1), pp. 7-12. Date of Electronic Publication: 2024 Jul 20.
Publication Type: Journal Article
Journal Info: Publisher: Sage Publications Country of Publication: United States NLM ID: 8900945 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-1937 (Electronic) Linking ISSN: 08971900 NLM ISO Abbreviation: J Pharm Pract Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1531-1937
DOI:10.1177/08971900241263164